Summary - GILD - NASDAQ - Weiss Ratings

C

Gilead Sciences, Inc. GILD

$114.43 -$2.78-2.37%

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

52-Week Range

$62.07 - $119.96

P/E (TTM)

EPS (TTM)

My Lists My Alerts

Biotechnology Health Care Pharmaceutical Drugs

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

These 3 Dividend Stocks Jumped 15% in a Month—More to Come?

3/11/2025 - MarketBeat

11 Best Pharma Stocks to Buy According to Hedge Funds

3/11/2025 - Insider Monkey

Gilead Sciences, Inc. (GILD) Leerink Partners Global Healthcare Conference - (Transcript)

3/11/2025 - SeekingAlpha

Gilead Sciences, Inc. (GILD) Leerink Partners Global Healthcare Conference - (Transcript)

3/11/2025 - Seeking Alpha: Transcripts

First Clinical Data for Gileads Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet

3/11/2025 - Business Wire

Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday

3/11/2025 - Benzinga

The Analyst Verdict: Gilead Sciences In The Eyes Of 14 Experts

3/11/2025 - Benzinga

Gables Capital Management Inc. Cuts Position in Gilead Sciences, Inc. (NASDAQ:GILD)

3/11/2025 - Ticker Report

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Dearborn Partners LLC

3/11/2025 - MarketBeat

Gilead Sciences's Options: A Look at What the Big Money is Thinking

3/10/2025 - Benzinga

Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson

3/10/2025 - Zacks Investment Research

Gilead Sciences (NASDAQ:GILD) Hits New 12-Month High - Should You Buy?

3/10/2025 - MarketBeat

Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year?

3/10/2025 - Zacks Investment Research

Ruffer LLP Makes New $6.50 Million Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

3/10/2025 - MarketBeat

AlphaQuest LLC Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

3/10/2025 - MarketBeat

M. Kulyk & Associates LLC Sells 11,801 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

3/10/2025 - MarketBeat

Investors Research Corp Has $1.07 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

3/10/2025 - MarketBeat

Ranch Capital Advisors Inc. Purchases 7,153 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

3/10/2025 - MarketBeat

Daiwa Securities Group Inc. Raises Position in Gilead Sciences, Inc. (NASDAQ:GILD)

3/10/2025 - MarketBeat

Zurcher Kantonalbank Zurich Cantonalbank Has $130.40 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)

3/10/2025 - MarketBeat

Argentarii LLC Invests $304,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

3/10/2025 - Ticker Report

PNC Financial Services Group Inc. Has $36.38 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)

3/10/2025 - MarketBeat

Bank Julius Baer & Co. Ltd Zurich Sells 36,080 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

3/10/2025 - MarketBeat

M. Kulyk & Associates LLC Reduces Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

3/9/2025 - Ticker Report

Gilead Sciences: 4 Reasons This Stock Has Much More To Rise

2/22/2025 - MarketBeat

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Friday, February 28, 2025

Period Date

Tuesday, December 31, 2024

Next Filing

Week of May 5 and 9 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

May 31, 2024 - $62.07

52-week High

Mar 10, 2025 - $119.96

Valuation

Market Cap

$145.97B - Large Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

Dividend Per Share (TTM)

Corporate Info

Website

Phone Number

650 574 3000

Address

333 Lakeside Drive
Foster City, CA 94404

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The... more